Identifying a neurochemical signature of the paraventricular nucleus of the thalamus that predicts individual variability in cue-reward learning
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
To investigate neurochemical factors that may confer vulnerability to psychiatric disorders, we used an animal model that captures a transdiagnostically relevant neurobehavioral endophenotype. During a Pavlovian conditioned approach (PavCA) paradigm, rats learn the predictive relationship between a lever-cue and food reward. A subset of rats, sign-trackers (STs), also attribute incentive motivational value to the lever-cue. Relative to non-sign-trackers (NSTs), STs are more impulsive, have attentional deficits, and show greater reinstatement of drug-seeking behavior. The paraventricular nucleus of the thalamus (PVT) is a key neural node implicated in these individual differences. We combined in vivo microdialysis with liquid chromatography–tandem mass spectrometry (LC-MS/MS) to quantify 22 neurobiologically relevant small molecules in the PVT before and 24 hours after PavCA training. Before training, PVT glucose concentrations were higher in rats subsequently classified as STs than in NSTs and were correlated with the PavCA index used to phenotype the rats. Glucose concentrations decreased after training, and the magnitude of change differed between phenotypes. Multivariate regression identified baseline PVT neurochemical profiles associated with subsequent PavCA behavior. These findings identify a candidate PVT neurochemical signature that precedes behavioral phenotyping and may mark the propensity to sign-track, providing insight into potential mechanisms underlying vulnerability to psychiatric disorders characterized by maladaptive cue-motivated behavior.